...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: THIS IS NEW ,,, What if

Stock, thanks for this.

I went back and read PVLees Dec 12th post at 9:41 a.m. and you are right. It really is worth a re-read!

This interpretation of ZCC makes sense and if that is the way it works out then Don has created a long term money generating machine for all of us Zenith holders.

Thanks to you and PVLee.

Cheers

Toinv

Share
New Message
Please login to post a reply